MedTrace Logo

Far Infrared Radiation for Sickle Cell Pain Management

NCT00599482 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2009-01-05

No results posted yet for this study

Summary

Most patients with sickle-cell disease have periodic intensely painful episodes. To manage this pain, we are proposing the drinking of at least 500 mL of water followed by far infrared radiation.

Conditions

  • Anemia, Sickle Cell

Interventions

RADIATION

Far Infrared Radiation (5μm to 20μm wavelength)

Far infrared radiation for 30 to 40 minutes during each session.

Sponsors & Collaborators

  • GAAD Medical Research Institute Inc.

    lead OTHER

Principal Investigators

  • Ken Nedd, M.D. · GAAD Medical Research Institute Inc.

  • Kwasi Donyina, Ph.D. · GAAD Medical Research Institute Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-09-30
Completion
2009-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00599482 on ClinicalTrials.gov